Neon Therapeutics, Inc.

NEON THERAPEUTICS

Pharmaceuticals, namely, immunotherapies; oncological preparations, namely, pharmaceutical products for the detection, prevention, and treatment of cancer; anti-cancer preparations; biological preparations for the treatment of cancer and oncological conditions; pharmaceutical products for the prevention and treatment of cancer and oncological conditions; synthetic peptides for the treatment of cancer and oncological conditions; and vaccine preparations;THERAPEUTICS;

NEON THERAPEUTICS

Medical and pharmaceutical consultation; and providing information relating to therapeutic properties of pharmaceuticals;THERAPEUTICS;Conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development services; pharmaceutical product evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer and oncological conditions; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platform for manufacturing therapeutics; conducting clinical trials for others in the field of pharmaceuticals for the treatment and prevention of cancer and oncological conditions; and consulting services for others in the field of design, planning, and implementation of clinical trials;

RECON

The mark consists of the word RECON in stylized letters centered on a radar screen formed by three concentric circles with a radial line extending from the center, and a DNA strand extending from the top of the outer circle to the bottom right of the outer circle.;Pharmaceuticals, namely immunomodulators; anti-cancer preparations; biological preparations for the treatment of cancer; pharmaceutical products for the prevention and treatment of cancer; synthetic peptides for the treatment of cancer; and vaccine preparations;Color is not claimed as a feature of the mark.;Medical and pharmaceutical consultation; and providing information relating to therapeutic properties of pharmaceuticals;Conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development services; pharmaceutical product evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; conducting clinical trials for others in the field of pharmaceuticals for the treatment and prevention of cancer; and consulting services for others in the field of design, planning, and implementation of clinical trials;